Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 1
1952 1
1954 2
1955 3
1957 2
1958 2
1959 1
1960 2
1961 3
1962 4
1963 5
1964 4
1965 7
1966 19
1967 7
1968 10
1969 15
1970 18
1971 15
1972 14
1973 15
1974 22
1975 16
1976 14
1977 17
1978 25
1979 30
1980 39
1981 25
1982 33
1983 37
1984 32
1985 40
1986 58
1987 52
1988 41
1989 75
1990 92
1991 86
1992 96
1993 99
1994 129
1995 122
1996 100
1997 104
1998 110
1999 122
2000 141
2001 134
2002 113
2003 158
2004 156
2005 167
2006 153
2007 134
2008 142
2009 154
2010 159
2011 185
2012 188
2013 183
2014 213
2015 189
2016 196
2017 186
2018 228
2019 235
2020 254
2021 258
2022 16
Text availability
Article attribute
Article type
Publication date

Search Results

5,305 results
Results by year
Filters applied: . Clear all
Page 1
Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial.
Saura C, Oliveira M, Feng YH, Dai MS, Chen SW, Hurvitz SA, Kim SB, Moy B, Delaloge S, Gradishar W, Masuda N, Palacova M, Trudeau ME, Mattson J, Yap YS, Hou MF, De Laurentiis M, Yeh YM, Chang HT, Yau T, Wildiers H, Haley B, Fagnani D, Lu YS, Crown J, Lin J, Takahashi M, Takano T, Yamaguchi M, Fujii T, Yao B, Bebchuk J, Keyvanjah K, Bryce R, Brufsky A; NALA Investigators. Saura C, et al. Among authors: yamaguchi m. J Clin Oncol. 2020 Sep 20;38(27):3138-3149. doi: 10.1200/JCO.20.00147. Epub 2020 Jul 17. J Clin Oncol. 2020. PMID: 32678716 Free PMC article. Clinical Trial.
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial.
Shimada K, Yamaguchi M, Atsuta Y, Matsue K, Sato K, Kusumoto S, Nagai H, Takizawa J, Fukuhara N, Nagafuji K, Miyazaki K, Ohtsuka E, Okamoto M, Sugita Y, Uchida T, Kayukawa S, Wake A, Ennishi D, Kondo Y, Izumi T, Kin Y, Tsukasaki K, Hashimoto D, Yuge M, Yanagisawa A, Kuwatsuka Y, Shimada S, Masaki Y, Niitsu N, Kiyoi H, Suzuki R, Tokunaga T, Nakamura S, Kinoshita T. Shimada K, et al. Among authors: yamaguchi m. Lancet Oncol. 2020 Apr;21(4):593-602. doi: 10.1016/S1470-2045(20)30059-0. Epub 2020 Mar 11. Lancet Oncol. 2020. PMID: 32171071 Clinical Trial.
DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase II study.
Miyazaki K, Asano N, Yamada T, Miyawaki K, Sakai R, Igarashi T, Nishikori M, Ohata K, Sunami K, Yoshida I, Yamamoto G, Takahashi N, Okamoto M, Yano H, Nishimura Y, Tamaru S, Nishikawa M, Izutsu K, Kinoshita T, Suzumiya J, Ohshima K, Kato K, Katayama N, Yamaguchi M. Miyazaki K, et al. Among authors: yamaguchi m. Haematologica. 2020 Sep 1;105(9):2308-2315. doi: 10.3324/haematol.2019.231076. Haematologica. 2020. PMID: 33054055 Free PMC article. Clinical Trial.
Randomized Controlled Trial of Trastuzumab With or Without Chemotherapy for HER2-Positive Early Breast Cancer in Older Patients.
Sawaki M, Taira N, Uemura Y, Saito T, Baba S, Kobayashi K, Kawashima H, Tsuneizumi M, Sagawa N, Bando H, Takahashi M, Yamaguchi M, Takashima T, Nakayama T, Kashiwaba M, Mizuno T, Yamamoto Y, Iwata H, Kawahara T, Ohashi Y, Mukai H; RESPECT study group. Sawaki M, et al. Among authors: yamaguchi m. J Clin Oncol. 2020 Nov 10;38(32):3743-3752. doi: 10.1200/JCO.20.00184. Epub 2020 Sep 16. J Clin Oncol. 2020. PMID: 32936713 Clinical Trial.
Exciting frontiers in drug hypersensitivity.
Yamaguchi M, Izuhara K. Yamaguchi M, et al. Allergol Int. 2019 Jul;68(3):287-288. doi: 10.1016/j.alit.2019.06.005. Allergol Int. 2019. PMID: 31266595 Free article. No abstract available.
The DNA polymerases of Drosophila melanogaster.
Marygold SJ, Attrill H, Speretta E, Warner K, Magrane M, Berloco M, Cotterill S, McVey M, Rong Y, Yamaguchi M. Marygold SJ, et al. Among authors: yamaguchi m. Fly (Austin). 2020 Mar-Dec;14(1-4):49-61. doi: 10.1080/19336934.2019.1710076. Epub 2020 Jan 14. Fly (Austin). 2020. PMID: 31933406 Free PMC article. Review.
Japan's Ongoing Crisis on HPV Vaccination.
Sekine M, Kudo R, Yamaguchi M, Hanley SJB, Hara M, Adachi S, Ueda Y, Miyagi E, Ikeda S, Yagi A, Enomoto T. Sekine M, et al. Among authors: yamaguchi m. Vaccines (Basel). 2020 Jul 6;8(3):362. doi: 10.3390/vaccines8030362. Vaccines (Basel). 2020. PMID: 32640691 Free PMC article. Review.
Japanese guidelines for occupational allergic diseases 2020.
Dobashi K, Usami A, Yokozeki H, Tsurikisawa N, Nakamura Y, Sato K, Okumura J, Yamaguchi M; Committee for Japanese Guideline for Diagnosis and Management of Occupational Allergic Disease, The Japanese Society of Allergology. Dobashi K, et al. Among authors: yamaguchi m. Allergol Int. 2020 Jul;69(3):387-404. doi: 10.1016/j.alit.2020.03.010. Epub 2020 May 27. Allergol Int. 2020. PMID: 32471740 Free article. Review.
Editorial: Host-Pathogen Interactions During Pneumococcal Infection.
Yamaguchi M, Kinjo Y, Nizet V. Yamaguchi M, et al. Front Cell Infect Microbiol. 2021 Oct 25;11:752959. doi: 10.3389/fcimb.2021.752959. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34760720 Free PMC article. No abstract available.
5,305 results